Molecules/REFANEZUMAB

REFANEZUMAB

Molecular Identity

AntibodyPhase 2

Mechanism of action: Myelin-associated glycoprotein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

GSK-249320GSK249320REFANEZUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to REFANEZUMAB

Loading drug network...